BIOMAT Database Logo BIOMAT Database Logo

[9-alpha-fluoroprednisolone in lotion and ointment in topical dermatological therapy]. 1971

L Andreassi, and A Valentino

UI MeSH Term Description Entries

Related Publications

L Andreassi, and A Valentino
[Hypermineralcorticism caused by topical preparation containing 9-alpha-fluoroprednisolone].
January 1988, Medicina cutanea ibero-latino-americana,
L Andreassi, and A Valentino
Hypermineralocorticoidism due to topical application of 9 alpha-fluoroprednisolone.
November 1984, Clinical nephrology,
L Andreassi, and A Valentino
[9-alpha-fluoroprednisolone in the topical therapy of occupational dermatosis caused by alkaline substances].
August 1968, Minerva dermatologica,
L Andreassi, and A Valentino
[Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].
January 1987, Neurologia (Barcelona, Spain),
L Andreassi, and A Valentino
[9-alpha-fluoroprednisolone in hepatic regeneration].
September 1958, Rivista di patologia e clinica,
L Andreassi, and A Valentino
[Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
December 1980, Medicina clinica,
L Andreassi, and A Valentino
Hypokalemic rhabdomyolysis secondary to pseudohyperaldosteronism due to the use of a lotion containing 9-alpha-fluoroprednisolone.
January 1986, Nephron,
L Andreassi, and A Valentino
[Hypokalemic myopathy and metabolic alkalosis secondary to the topical application of 9-alpha-fluoroprednisolone].
September 1983, Revista clinica espanola,
L Andreassi, and A Valentino
[16 alpha-Methyl-9 alpha-fluoroprednisolone; preliminary note].
February 1959, El Dia medico,
L Andreassi, and A Valentino
Rhabdomyolysis, oedema and arterial hypertension: different syndromes related to topical use of 9-alpha-fluoroprednisolone.
October 1988, Journal of human hypertension,
Copied contents to your clipboard!